A phase IB clinical trial of the multitargeted kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Molina, A. M.; Hutson, T. E.; Larkin, J.; Gold, A.; Andresen, C.; Wood, K.; Motzer, R. J.; Michaelson, M. D. |
| Abstract Title: | A phase IB clinical trial of the multitargeted kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC) |
| Meeting Title: | 37th Congress of the European Society for Medical Oncology (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 23 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2012 Sep 28-Oct 2 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2012-09-01 |
| Start Page: | ix269 |
| Language: | English |
| ACCESSION: | WOS:000309409001296 |
| PROVIDER: | wos |
| PUBMED: | 23012731 |
| DOI: | 10.1093/annonc/mds399 |
| Notes: | Meeting Abstract: 814P -- "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
